14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SRTM vs TVGN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over SRTM (SRTM) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). SRTM carries a Unified Composite Score of 47.6/100 (HOLD) at $0.08 (N/M Forward P/E, N/A operating margin), whereas TVGN carries 51.6/100 (HOLD) at $5.90 (N/M Forward P/E, 0.0% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs TVGN. Trailing 12-month operating profitability (SRTM N/A vs TVGN 0.0%) and valuation multiples (SRTM N/M vs TVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $432.7M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SRTM vs TVGN Key Questions & Quantitative Answers
As of Nov 20, 2026, Tevogen Bio Holdings Inc. (TVGN) is the stronger overall head-to-head candidate over SRTM (SRTM) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). SRTM carries a Unified Composite Score of 47.6/100 (HOLD) at $0.08 (N/M Forward P/E, N/A operating margin), whereas TVGN carries 51.6/100 (HOLD) at $5.90 (N/M Forward P/E, 0.0% operating margin). Technically, SRTM sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and TVGN sits in a Neutral phase (RSI 46.4, UNCLASSIFIED options structure).
TVGN leads the Growth & Scale pillar: SRTM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TVGN at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, SRTM generates N/A in USD-normalized revenue versus N/A for TVGN. In operating R&D and SG&A reinvestment, SRTM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TVGN.
SRTM and TVGN trade at balanced relative valuation multiples. SRTM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TVGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SRTM (N/A ROE) versus TVGN (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, SRTM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, TVGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.32β · 69% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.